Insider Holders & Insider Ownership - ENDO INTL PLC (ENDPQ)

List of insiders holdings for ENDO INTL PLC:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Holder NameReport
Date Time		Shares Owned
Directly
Indirectly		Total
Shares Owned		Filing
Campanelli Paul
Director		2021-04-06 16:46:461,607,550
0		1,607,550Form 4
Coleman Blaise
President, CEO		2022-03-31 16:02:21422,066
0		422,066Form 4
Coughlin Terrance J
EVP, Chief Operating Officer		2020-08-12 16:08:41356,644
0		356,644Form 4
HYATT MICHAEL
Director		2021-06-15 16:07:46345,185
10,375		355,560Form 4
DE SILVA RAJIV
President & CEO		2016-03-22 16:10:37291,695
63,315		355,010Form 4
Maletta Matthew Joseph
EVP, CLO & Company Secretary		2022-03-31 16:06:44351,085
0		351,085Form 4
KIMMEL ROGER H
Director		2020-06-16 16:09:52136,575
80,000		216,575Form 4
Barry Patrick A
EVP & Pres,Global Comm Ops		2022-03-31 16:09:54169,711
0		169,711Form 4
MONTAGUE WILLIAM P
Director		2021-06-15 16:01:45112,025
10,000		122,025Form 4
Hutson Nancy J
Director		2021-06-15 16:06:23116,140
0		116,140Form 4
Bradley Mark T.
EVP, Chief Financial Officer		2022-03-31 16:03:46101,477
0		101,477Form 4
Cooke Shane
Director		2021-06-15 16:10:20100,034
0		100,034Form 4
MANOGUE CAROLINE B
Exec. V.P.,Chief Legal Officer		2015-04-09 17:16:2090,202
0		90,202Form 4
Gergel Ivan P.
EVP, R&D and CSO		2014-03-11 20:18:0379,980
0		79,980Form 4
Mansukani Sharad
Director		2019-06-14 19:32:5771,523
0		71,523Form 4
Pera Antonio R
President, Par Pharmaceutical		2019-04-04 16:36:0765,648
0		65,648Form 4
Boyle Jack D.
SVP, Controller		2021-04-06 17:01:3059,868
0		59,868Form 4
Ciaffoni Joseph
President, U.S. Branded Pharma		2016-08-18 11:15:3059,424
0		59,424Form 4
Ciarico Domenico
EVP & Chief Commercial Officer		2020-09-08 16:05:1155,958
0		55,958Form 4
Garella Rahul
EVP, Intl Pharmaceuticals		2020-08-12 16:18:2355,244
0		55,244Form 4
HIGGINS ARTHUR J
Director		2016-05-12 13:08:0050,623
0		50,623Form 4
Spengler William
Director		2016-03-17 19:03:0848,835
0		48,835Form 4
Smith Jill D.
Director		2017-06-12 21:43:4943,719
0		43,719Form 4
Barberio Mark G
Director		2021-06-15 16:03:2038,187
0		38,187Form 4
Smith Mary Christine
Director		2021-06-15 16:04:4632,819
0		32,819Form 4
DELUCCA JOHN
Director		2015-03-06 16:19:0832,343
0		32,343Form 4
Chao Jennifer M
Director		2021-06-15 16:09:0424,921
0		24,921Form 4
Lortie Brian
President Branded Pharma		2016-03-04 16:45:2924,504
0		24,504Form 4
Upadhyay Suketu
EVP, Chief Financial Officer		2016-09-27 16:03:4422,412
0		22,412Form 4
INGRAM DOUGLAS S
Director		2017-06-12 21:40:4517,336
0		17,336Form 4
Nichol Carrie Ann
SVP, Controller & CAO		2019-08-13 17:52:3914,096
0		14,096Form 4
Rudio Daniel
SVP, Controller		2018-02-27 16:37:549,669
0		9,669Form 4
Raciti Frank B.
VP, Controller and CAO		2022-03-31 16:08:178,821
0		8,821Form 4
Apostol George
EVP, Global R&D		2021-06-03 16:03:267,331
0		7,331Form 4
DeGolyer Donald W
Chief Operating Officer,Pharma		2015-03-02 17:21:496,547
0		6,547Form 4
Hall Susan
EVP, CSO, Global Head of R&D		2016-03-14 17:53:104,826
0		4,826Form 4
Varghese Hemanth Jacob
Pres. International Pharma		2016-05-02 16:46:274,350
0		4,350Form 4
Sisitsky Todd Benjamin
Director		2016-05-05 17:28:560
0		0Form 3
Farhat Camille
President, AMS, Inc.		2015-03-12 17:25:230
0		0Form 4
Tursi James Patrick
Executive VP, Global R&D		2022-08-17 06:31:280
0		0Form 4